CalciMedica is a privately held, clinical stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases. The Company was founded in 2007 by Ken Stauderman, CalciMedica’s Chief Scientific Officer, and colleagues at Torrey Pines Therapeutics in San Diego and Harvard’s Center for Blood Research in Cambridge, MA. Dr. Stauderman’s work includes the discovery of the role of STIM1, which works in concert with Orai1 in the CRAC channels targeted by CalciMedica’s drugs. The Company has a portfolio of highly selective CRAC channel inhibitor drugs that it is developing to improve outcomes for patients with acute inflammatory indications. It has also assembled a portfolio of patents and patent applications covering those compounds as well as different aspects of CRAC channel biology.
Location: United States, California, La Jolla
Employees: 11-50
Total raised: $36M
Founded date: 2007
Investors 4
| Date | Name | Website |
| - | Bioscience... | bioscience... |
| - | Valence Li... | valencefun... |
| 30.08.2023 | OrbiMed | orbimed.co... |
| - | Quark Vent... | quarkventu... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 11.03.2021 | Series D | $21M | - | globenewsw... |
| 25.05.2020 | Series C | $15M | - | finsmes.co... |
Mentions in press and media 10
| Date | Title | Description | Source |
| 09.09.2021 | CalciMedica Announces Publication of Preclinical Data in Jou... | LA JOLLA, Calif., Sept. 9, 2021 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the &... | prnewswire... |
| 02.06.2021 | CalciMedica Publishes Positive Data from Phase 2a Study of A... | LA JOLLA, Calif., June 2, 2021 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the &q... | prnewswire... |
| 11.03.2021 | CalciMedica Announces $21 Million Series D Financing | Round led by Quark Venture LP and Global Health Sciences (GHS) Fund Funds to support advancement of... | globenewsw... |
| 11.03.2021 | CalciMedica has raised a $21M Series D to advance their anti... | - | connect.or... |
| 25.05.2020 | CalciMedica Raises $15M in Series C Financing | CalciMedica Inc., a La Jolla, Calif.-based clinical-stage biotechnology company targeting calcium re... | finsmes.co... |
| 22.05.2020 | CalciMedica Raises $15M in Series C Financing | - | connect.or... |
| 15.12.2009 | CalciMedica Closes Second Tranche of $12M Series C Financing | CalciMedica, a La Jolla, California-based biotechnology company dedicated to the discovery and devel... | finsmes.co... |
| 12.02.2008 | Life sciences briefing: Tuesday, Feb. 12, 2008 | TODAY’S HEADLINES: Metabolic-disease biotech NGM Biopharma raises $25M (peHUB) Heart, HIV drug mak... | venturebea... |
| 31.07.2007 | CalciMedica raises $1.5M for inflammatory disease | CalciMedica, a San Diego biotech focused on autoimmune and inflammatory disease, raised $1.53 millio... | venturebea... |
| - | CalciMedica | “Leading CRAC Channel Company Delivering Drug Candidates For Inflammatory Diseases of High Unmet Nee... | fastfounde... |